Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit

Clinical observations stemming from widespread employment of restorative L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for management of dyskinesia in Parkinson’s Disease (PD) patients implicate a regulatory role for endogenous morphine in central nervous system dopamine neurotransmission. Reciproca...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefano, George B., Mantione, Kirk J., Králíčková, Milena, Ptacek, Radek, Kuzelova, Hana, Esch, Tobias, Kream, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560700/
https://www.ncbi.nlm.nih.gov/pubmed/22847214
http://dx.doi.org/10.12659/MSM.883259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560700/
https://www.ncbi.nlm.nih.gov/pubmed/22847214
http://dx.doi.org/10.12659/MSM.883259

Ejemplares similares